-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025
-
-
-
-
-
-
-
NRx Pharmaceuticals (NRXP) Reschedules Q3 Call
-
-
-
-
-
-
-
NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
-
-
-
-
-
-
-
NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NRXP) Misses Q1 EPS by 2c
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NRXP) Reports In-Line Q3 EPS
-
1,198,551 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

